SCHEMBL30856006

SCHEMBL30856006

O=Cc1c([N+](=O)[O-])cc2c(c(F)nn2CC(F)F)c1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30856403 0.83 CYP1A2 (0.41) —
SCHEMBL30855874 0.82 KDM4E (0.30) —
SCHEMBL30855748 0.73 LMNA (0.32) —
SCHEMBL10076076 0.72 TDP1 (0.36) —
SCHEMBL30856300 0.72 MEN1 (0.33) —
SCHEMBL14908669 0.64 CNR2 (0.44) —
SCHEMBL18164170 0.64 KMT2A (0.40) —
SCHEMBL28483269 0.62 CNR2 (0.42) —
SCHEMBL30695536 0.62 CNR2 (0.42) —
SCHEMBL31468224 0.62 ERN1 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152713-A Tricyclic aryl derivatives and compositions and methods thereof 昂胜医疗科技公司 2025-06-13 — — CN disclosed
EP-4561562-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Ensem Therapeutics, Inc. (US) 2025-06-04 — — EP disclosed
WO-2024026128-A2 TRICYCLIC ARYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback